| NCT Number | NCT07300358 |
| Lead Sponsor | Shanghai Lingsi Medical Technology Co., Ltd. |
| Conditions | Cardiovascular Diseases, Cardiovascular Abnormality, Heart Defects, Congenital, Heart Septal Defects, Heart Septal Defects, Atrial, Foramen Ovale, Patent, Stroke, Ischemic, Stroke (CVA) or TIA |
| Enrollment | 258 participants |
| Start Date | 2025-12-30 |
| Primary Completion | 2027-06-30 (estimated) |
| Study Completion | 2027-06-30 (estimated) |
| Updated on ClinicalTrials.gov | 2025-12-23 |